Johnson & Johnson raises outlook despite flood of litigation
16 October 2019 - 06:01
Bengaluru — Johnson & Johnson (J&J) raised its full-year earnings forecast on Tuesday as it reported higher third-quarter sales while attempting to alleviate investor concerns over mounting legal challenges.
Shares of the US healthcare conglomerate, which also has huge medical devices and consumer products units, rose 2% to $133.70, contributing to a strong early performance on Wall Street overall on Tuesday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.